Pancreatic Diseases
Pathological processes of the PANCREAS.
Subtype terms (8)
More specific conditions that are subtypes of Pancreatic Diseases in the MeSH hierarchy.
- Congenital Hyperinsulinism
17 drugs (13 approved, 4 experimental)
- Cystic Fibrosis
329 drugs (163 approved, 166 experimental)
- Exocrine Pancreatic Insufficiency
24 drugs (12 approved, 12 experimental)
- Pancreas Divisum
- Pancreatic Cyst
6 drugs (5 approved, 1 experimental)
- Pancreatic Fistula
11 drugs (10 approved, 1 experimental)
- Pancreatic Neoplasms
1361 drugs (372 approved, 989 experimental)
- Pancreatitis
105 drugs (77 approved, 28 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (10)
Phase 3 trials (12)
Phase 2 trials (11)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (38)
- Celgene
- ChiRhoClin, Inc.
- Allegiance Health
- Changhai Hospital
- Harvard University
- Emory University
- Temple University
- Indiana University
- Johns Hopkins University
- McMaster University
- Ohio State University
- Providence Health & Services
- Rhode Island Hospital
- Thomas Jefferson University
- University of Iowa
- University of Ottawa
- University of Toronto
- University of Alberta
- Mayo Clinic
- Stony Brook University
- St. Louis University
- University of California, Davis
- University of Chicago
- University of Utah
- Gundersen Health System
- Pennsylvania State University
- University of Wisconsin
- University of Alabama, Birmingham
- Washington University in St. Louis
- Yeshiva University
- +8 more
Organization Involved with Phase 2 Indications (4)
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (6)